AstraZeneca's Q3 profit drops by 35% - EIU Country Analysis

AstraZeneca's Q3 profit drops by 35%

AstraZeneca's Q3 profit drops by 35% - EIU Country Analysis
AstraZeneca's Q3 profit drops by 35%
Published Nov 13, 2017
206 words — Published Nov 13, 2017
Price US$ 37.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

On November 9th AstraZeneca Plc reported a 35% drop in its net profit to US$649m for the third quarter of 2017, hurt by higher cost of sales and lower tax gains compared with a year earlier. The UK drugmaker's third-quarter revenue rose...

  
Source:
Geography / Regions
Industry
Healthcare, Pharmaceuticals and biotechnology
Format:
HTML HTML
Buy Now

EIU Country Analysis—The Economist Intelligence Unit, a division of London's Economist Group, is the most respected provider of country analysis for governments, multi-national corporations and financial institutions around the world. Through our network of over 500 international contributor economists, we establish independent macro-economic outlooks and detailed reports on the political and commercial environments for over 200 countries around the world.

About the Author


Cite this Report

  
MLA:
EIU Country Analysis. "AstraZeneca's Q3 profit drops by 35%" Nov 13, 2017. Alacra Store. Nov 19, 2017. <http://news.alacrastore.com/eiu-news/AstraZeneca-s-Q3-profit-drops-by-35-IWHLTH_IWHLTH_MAIN_20171113T182225_0001>
  
APA:
EIU Country Analysis. (). AstraZeneca's Q3 profit drops by 35% Nov 13, 2017. New York, NY: Alacra Store. Retrieved Nov 19, 2017 from <http://news.alacrastore.com/eiu-news/AstraZeneca-s-Q3-profit-drops-by-35-IWHLTH_IWHLTH_MAIN_20171113T182225_0001>
  
US$ 37.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.